XML 30 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Cash Flows - ARS ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Income (Loss) for the year $ 272,128 $ 191,387 $ (44,014)
Adjustments to reconcile net (loss) income to net cash flows from operating activities:      
Depreciation of property, plant and equipment 154,559 180,208 123,377
Depreciation of right-of-use assets 10,620 6,161 7,003
Loss on disposals of property, plant and equipment 4,150 1,937 2,361
Net accrued interest 332,772 693,591 593,796
Income from customer surcharges (22,977) (30,492) (20,555)
Exchange difference 14,039 105,238 (10,026)
Income tax (78,850) 205,333 26,135
Allowance for the impairment of trade and other receivables, net of recovery 9,474 14,506 14,910
Adjustment to present value of receivables 5,848 3,071 2,295
Provision for contingencies, net of recovery 23,739 21,164 29,875
Changes in fair value of financial assets and financial liabilities 54,697 (73,557) (19,160)
Accrual of benefit plans 13,650 5,286 8,151
Result from the cancelattion of Corporate Notes 2,465
Loss on debt restructuring 3,447 3,044
Income from non-reimbursable customer contributions (760) (343) (418)
Investment plan - Agreement on the Regularization of Obligations (23,201)
Other financial costs 41,990 33,378 31,077
Result from interest in joint ventures 13 21 37
Agreement on the Regularization of Obligations (430,587) (122,991)
Recovery of allowance for the impairment of trade receivables - Agreement on the Regularization of Obligations (17,970)
Monetary gain (RECPAM) (610,414) (989,926) (675,514)
Changes in operating assets and liabilities:       
Increase in trade receivables  (282,218) (64,889) (46,989)
Increase in other receivables  (16,280) (8,358) (81,167)
Increase in inventories (46,414) (24,026) (15,727)
Increase in deferred revenue 76,987 2,047 13,915
Increase in trade payables 314,968 240,352 419,382
Increase in salaries and social security payable 39,135 41,321 35,243
Decrease in benefit plans (563) (1,023) (1,810)
Increase (Decrease) in tax liabilities 25,665 7,149 (3,166)
(Decrease) Increase in other payables (66,231) 28,581 (9,026)
Decrease in provisions (4,056) (1,888) (3,641)
Payment of income tax payable (651)
Net cash flows generated by operating activities 245,917 155,642 240,241
Cash flows from investing activities      
Payment of property, plants and equipments  (359,966) (260,838) (215,144)
Purchase (Sale) net of Mutual funds and negotiable instruments (207,162) 88,670 (37,146)
Derivative financial instruments payments (1,065)
Payment for establishment of subsidiary (117)
Net cash flows used in investing activities (567,245) (172,168) (253,355)
Cash flows from financing activities      
Proceeds from borrowings 349,312 37,943 29,973
Payment of borrowings (22,464) (2,247) (41,218)
Payment of lease liability (12,132) (14,070) (7,942)
Payment of interests from borrowings (30,703) (4,044) (6,076)
Payment of Corporate Notes issuance expenses (18,837) (1,603) (3,830)
Net cash flows generated by (used in) financing activities 265,176 15,979 (32,294)
Decrease in cash and cash equivalents (56,152) (547) (45,408)
Cash and cash equivalents at the beginning of the year 19,877 11,054 41,902
Exchange differences in cash and cash equivalents 5,150 9,821 14,736
Result from exposure to inflation (426) (451) (176)
Cash and cash equivalents at the end of the year (31,551) 19,877 11,054
Supplemental cash flows information      
Adquisition of advances to suppliers, property, plant and equipment through increased trade payables (29,249) (8,381) (14,751)
Adquisition of advances to suppliers, right-of-use assets through increased trade payables $ (13,363) $ (9,072) $ (6,184)